Legal & General Group Plc Reduces Stock Position in JFrog Ltd. $FROG

Legal & General Group Plc cut its stake in shares of JFrog Ltd. (NASDAQ:FROG) by 2.9% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 481,583 shares of the company’s stock after selling 14,241 shares during the period. Legal & General Group Plc owned about 0.42% of JFrog worth $21,132,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of FROG. Vanguard Group Inc. grew its holdings in shares of JFrog by 0.4% in the first quarter. Vanguard Group Inc. now owns 8,871,984 shares of the company’s stock worth $283,903,000 after acquiring an additional 35,458 shares during the period. T. Rowe Price Investment Management Inc. lifted its holdings in JFrog by 65.1% in the first quarter. T. Rowe Price Investment Management Inc. now owns 2,630,179 shares of the company’s stock valued at $84,166,000 after acquiring an additional 1,037,482 shares during the period. Alliancebernstein L.P. boosted its position in JFrog by 1,974.0% in the first quarter. Alliancebernstein L.P. now owns 2,151,008 shares of the company’s stock worth $68,832,000 after purchasing an additional 2,047,294 shares during the last quarter. JPMorgan Chase & Co. grew its stake in shares of JFrog by 3.0% during the 2nd quarter. JPMorgan Chase & Co. now owns 1,903,396 shares of the company’s stock valued at $83,521,000 after purchasing an additional 56,213 shares during the period. Finally, Praesidium Investment Management Company LLC increased its position in shares of JFrog by 8.4% during the 1st quarter. Praesidium Investment Management Company LLC now owns 1,590,388 shares of the company’s stock valued at $50,892,000 after purchasing an additional 123,160 shares during the last quarter. 85.02% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several analysts recently issued reports on FROG shares. Cantor Fitzgerald boosted their target price on shares of JFrog from $60.00 to $70.00 and gave the company an “overweight” rating in a research report on Friday, November 7th. KeyCorp lifted their price target on shares of JFrog from $57.00 to $71.00 and gave the stock an “overweight” rating in a research note on Friday, November 7th. Truist Financial restated a “buy” rating and issued a $70.00 price objective (up from $55.00) on shares of JFrog in a research note on Friday, November 7th. Stifel Nicolaus lifted their target price on JFrog from $45.00 to $53.00 and gave the company a “buy” rating in a research report on Friday, August 8th. Finally, Oppenheimer raised JFrog from a “market perform” rating to an “outperform” rating and set a $75.00 price target for the company in a report on Friday, November 7th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $62.69.

Insiders Place Their Bets

In other JFrog news, CEO Ben Haim Shlomi sold 15,000 shares of the stock in a transaction that occurred on Thursday, November 6th. The shares were sold at an average price of $46.01, for a total transaction of $690,150.00. Following the completion of the sale, the chief executive officer directly owned 4,869,152 shares of the company’s stock, valued at $224,029,683.52. This trade represents a 0.31% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CRO Tali Notman sold 13,067 shares of the business’s stock in a transaction on Monday, September 8th. The stock was sold at an average price of $50.26, for a total transaction of $656,747.42. Following the completion of the transaction, the executive directly owned 658,842 shares in the company, valued at $33,113,398.92. This trade represents a 1.94% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 385,125 shares of company stock worth $20,781,626. Company insiders own 14.10% of the company’s stock.

JFrog Stock Performance

FROG opened at $60.97 on Friday. JFrog Ltd. has a fifty-two week low of $27.00 and a fifty-two week high of $65.50. The firm’s fifty day moving average is $51.91 and its 200 day moving average is $46.62. The stock has a market cap of $7.21 billion, a price-to-earnings ratio of -87.10 and a beta of 1.02.

JFrog (NASDAQ:FROG) last issued its quarterly earnings results on Thursday, November 6th. The company reported $0.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.16 by $0.06. The business had revenue of $136.91 million during the quarter, compared to analyst estimates of $128.28 million. JFrog had a negative return on equity of 6.69% and a negative net margin of 15.88%.JFrog’s revenue for the quarter was up 25.5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.15 EPS. JFrog has set its FY 2025 guidance at 0.780-0.800 EPS. Q4 2025 guidance at 0.180-0.200 EPS. On average, equities research analysts predict that JFrog Ltd. will post -0.33 earnings per share for the current year.

About JFrog

JFrog Ltd. provides end-to-end hybrid software supply chain platform in the United States, Israel, India, and internationally. The company offers JFrog Artifactory, a package repository that allows teams and organizations to store, update, and manage their software packages; JFrog Curation that functions as a guardian outside the software development pipeline, controlling the admission of packages into an organization, primarily from open source or public repositories; JFrog Xray, which scans JFrog Artifactory to secure all software packages; JFrog Advanced Security, an optional add-on for select JFrog subscriptions; and JFrog Distribution that provides software package distribution.